Allspring Global Investments Holdings, LLC Aerie Pharmaceuticals Inc Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022
SELL
$6.37 - $15.23 $2,535 - $6,061
-398 Reduced 1.09%
35,952 $543,000
Q2 2022

Jul 25, 2022
BUY
$4.95 - $9.16 $56,731 - $104,982
11,461 Added 46.05%
36,350 $272,000
Q1 2022

May 02, 2022
SELL
$5.64 - $9.8 $156,081 - $271,205
-27,674 Reduced 52.65%
24,889 $226,000
Q4 2021

Jan 28, 2022
BUY
$7.02 - $13.33 $368,992 - $700,664
52,563 New
52,563 $368,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email